Dostarlimab

Cancer vanished in 100% of the patients, after 6 months trial with a drug, Dostarlimab, with no significant side effects, first time in history of cancer. Colorectal/rectal cancer the 5th commonest cancer in Africa, and usually by the time its diagnosed it would have spread throughout the body giving low survival rates with the traditional…